SAN DIEGO, May 8 /PRNewswire-FirstCall/ —ACADIA Pharmaceuticals Inc.(Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology tofuel drug discovery and clinical development of novel treatments for centralnervous system disorders, today announced that it will present at thefollowing investor conferences:
- The Rodman & Renshaw 3rd Annual Global Healthcare Conference on Monday,May 15, 2006, at 10:50 a.m. Central European Time at Le Meridien BeachPlaza Hotel in Monte Carlo, Monaco.
- The Banc of America Health Care Conference on Wednesday, May 17, 2006,at 1:20 p.m. Pacific Time at The Four Seasons Hotel in Las Vegas,Nevada.
- The BioEquity Europe 2006 Conference on Monday, May 22, 2006, at11:00 a.m. Central European Time at The Frankfurt Marriott Hotel inFrankfurt, Germany.
Live webcasts of ACADIA's presentations at each of the Rodman & Renshawand Banc of America Conferences will be accessible on the company's website,www.acadia-pharm.com, under the investors section and an archived recordingwill be available on the website through May 31, 2006.
About ACADIA Pharmaceuticals
ACADIA is a biopharmaceutical company utilizing innovative technology tofuel drug discovery and clinical development of novel treatments for centralnervous system disorders. ACADIA currently has five Phase II-stage clinicalprograms as well as a portfolio of preclinical and discovery assets directedat large unmet medical needs, including schizophrenia, Parkinson's disease,sleep maintenance insomnia, and neuropathic pain. All of the drug candidatesin ACADIA's product pipeline emanate from discoveries made using itsproprietary drug discovery platform. ACADIA's corporate headquarters islocated in San Diego, California and it maintains research and developmentoperations in both San Diego and Malmo, Sweden.
Contacts:
ACADIA Pharmaceuticals Inc.
Lisa Barthelemy, Director, Investor Relations
Thomas H. Aasen, Vice President and Chief Financial Officer
(858) 558-2871